Solventum appoints new chief accounting officer

Solventum Corporation appointed Neil Zieselman as Senior Vice President, Controller and Chief Accounting Officer, effective August 10, 2026.

Accepted by SEC EDGAR 07/20/2026 - 04:15 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Solventum Corporation appointed Neil Zieselman as Senior Vice President, Controller and Chief Accounting Officer, effective August 10, 2026. He will report to Chief Financial Officer Wayde McMillan, serve as the company’s Principal Accounting Officer for SEC reporting, and replace Mary Wilcox following her previously announced retirement.

Zieselman, age 50, joins from Surgery Partners, Inc., where he was Senior Vice President, Corporate Finance and Controller. His prior roles include senior finance leadership positions at Stryker Corporation, Covanta Holding Corporation, Cendant Corporation and Avaya Inc. He began his career at PricewaterhouseCoopers, is a licensed CPA, and graduated summa cum laude from Rider University.

His compensation includes an annual base salary aligned with role scope and experience, a target annual bonus of 50% of base salary, eligibility for an annual long-term incentive target award of $500,000, a cash sign-on bonus of $130,000, and an initial grant of $600,000 in restricted stock units vesting in three equal installments, plus participation in the Solventum Executive Severance Plan.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Key Figures

Target annual bonus: 50% of base salary Annual long-term incentive target: $500,000 Cash sign-on bonus: $130,000 +1 more

4 metrics

Target annual bonus 50% of base salary Target bonus as Senior Vice President, Controller and Chief Accounting Officer

Annual long-term incentive target $500,000 Eligible annual long-term incentive award for the role

Cash sign-on bonus $130,000 One-time cash sign-on bonus granted upon appointment

Initial RSU grant $600,000 Restricted stock units vesting in three equal installments over three years

Key Terms

Principal Accounting Officer, restricted stock units, long-term incentive, Solventum Executive Severance Plan, +1 more

5 terms

Principal Accounting Officer regulatory

"will function as the Company’s Principal Accounting Officer for Securities"

The Principal Accounting Officer is the person responsible for making sure a company's financial records are accurate and follow the rules. They play a key role in preparing financial reports that show how well the company is doing. This helps investors, managers, and regulators trust the company's financial information.

restricted stock units financial

"an initial grant of $600,000 of restricted stock units, which will vest"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

long-term incentive financial

"eligible for an annual long-term incentive target award of $500,000"

Long-term incentive is a form of pay awarded to executives and key employees that vests over several years and is tied to company performance, often paid in stock or stock-linked awards. It matters to investors because it shapes management’s motivation and risk-taking, can dilute existing shares, and affects future cash flow and company governance—think of it as a multi-year performance bonus that aligns leaders’ rewards with shareholder returns.

Solventum Executive Severance Plan financial

"he is eligible to participate in the Solventum Executive Severance Plan"

Item 404(a) of Regulation S-K regulatory

"no transactions between Mr. Zieselman and the Company that are required to be reported under Item 404(a)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What executive change did Solventum (SOLV) announce on July 16, 2026?

Solventum appointed Neil Zieselman as Senior Vice President, Controller and Chief Accounting Officer, effective August 10, 2026. He succeeds Mary Wilcox, who is retiring, and will act as Solventum’s Principal Accounting Officer for SEC reporting, reporting directly to the Chief Financial Officer.

What is Neil Zieselman’s background before joining Solventum (SOLV)?

Before Solventum, Zieselman was Senior Vice President, Corporate Finance and Controller at Surgery Partners, Inc.. He previously held senior finance roles at Stryker Corporation and Covanta Holding Corporation, among others, is a licensed CPA, and graduated summa cum laude in accounting from Rider University.

What compensation package will Neil Zieselman receive at Solventum (SOLV)?

Zieselman will receive a base salary, a target annual bonus of 50% of base salary, eligibility for a long-term incentive target award of $500,000, a cash sign-on bonus of $130,000, and an initial grant of $600,000 in restricted stock units vesting over three years.

How will Neil Zieselman’s restricted stock units at Solventum (SOLV) vest?

Zieselman’s initial grant of $600,000 in restricted stock units will vest in three equal installments on the first three anniversaries of the grant date, subject to his continued employment with Solventum throughout the vesting period.

Is Neil Zieselman eligible for severance benefits at Solventum (SOLV)?

Yes. As a result of his appointment, Zieselman is eligible to participate in the Solventum Executive Severance Plan. The plan’s detailed terms are described in a separate SEC filing referenced in the company’s current disclosure.

Are there any related-party or family relationships involving Neil Zieselman at Solventum (SOLV)?

The company states there is no family relationship between Zieselman and any Solventum director or executive officer, and no transactions with him requiring disclosure under Item 404(a) of Regulation S-K.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

FALSE000196473800019647382026-07-162026-07-16

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): July 16, 2026

SOLVENTUM CORPORATION

(Exact Name of Registrant as Specified in Its Charter)

Delaware

File No. 001-41968

92-2008841

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

1750 Yankee Doodle Road, Eagan, Minnesota

55121

(Address of Principal Executive Offices)

(Zip Code)

(Registrant’s Telephone Number, Including Area Code) (651) 733-1110

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, Par Value $.01 Per Share

SOLV

New York Stock Exchange

Securities registered pursuant to section 12(g) of the Act: None

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company     ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the exchange Act.     ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On July 16, 2026, the Board of Directors of Solventum Corporation (the “Company”) appointed Neil Zieselman to serve as Senior Vice President, Controller and Chief Accounting Officer of the Company, effective as of August 10, 2026. Mr. Zieselman is replacing Mary Wilcox in this role in connection with her previously announced retirement and will report directly to Wayde McMillan, the Company’s Chief Financial Officer. Mr. Zieselman will function as the Company’s Principal Accounting Officer for Securities and Exchange Commission (“SEC”) reporting purposes.

Mr. Zieselman, age 50, joins the Company from Surgery Partners, Inc., where he has served as its Senior Vice President, Corporate Finance and Controller since May 2022. Prior to Surgery Partners, Inc., Mr. Zieselman served Stryker Corporation as its Vice President, Finance Operations from April 2021 to May 2022, Senior Director, Finance Transformation from August 2019 to April 2021 and Senior Director, Finance and Group Controller, Orthopaedics Group from January 2017 to August 2019. Prior to joining Stryker Corporation, Mr. Zieselman held accounting and finance leadership roles at Covanta Holding Corporation, including Vice President and Chief Accounting Officer, Cendant Corporation and Avaya Inc. Mr. Zieselman began his career as an auditor with PricewaterhouseCoopers LLP. Mr. Zieselman is a licensed CPA and graduated Summa Cum Laude with a Bachelors of Science degree in Accounting from Rider University.

In connection with Mr. Zieselman’s appointment as Senior Vice President, Controller and Chief Accounting Officer, Mr. Zieselman’s compensation will consist of an annual base salary materially consistent with the scope of role and experience, and a target annual bonus of 50% of base salary, subject to employment on the applicable payment date. Mr. Zieselman will be eligible for an annual long-term incentive target award of $500,000. Mr. Zieselman will receive a cash sign-on bonus of $130,000 and an initial grant of $600,000 of restricted stock units, which will vest in three equal installments on the first three anniversaries of the grant date, subject to continued employment. Additionally, as a result of Mr. Zieselman’s appointment, he is eligible to participate in the Solventum Executive Severance Plan. For more information on the Solventum Executive Severance Plan, see the Current Report on Form 8-K filed with the SEC on May 27, 2026.

The appointment of Mr. Zieselman was not pursuant to any agreement or understanding between him and any other person. There is no family relationship between Mr. Zieselman and any director or executive officer of the Company, and there are no transactions between Mr. Zieselman and the Company that are required to be reported under Item 404(a) of Regulation S-K.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

			SOLVENTUM CORPORATION
			By:			/s/ Wayde McMillan
						Wayde McMillan
						Executive Vice President and Chief Financial Officer

Dated: July 20, 2026

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 1.8 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT 21.1 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT 12.2 KB